Shockwave shares are trading higher Tuesday following a report suggesting Johnson & Johnson is in talks to acquire the company. People familiar with the matter say that a deal to acquire the company ...
This launch is expected to broaden treatment options for patients affected by peripheral artery disease (PAD).
J&J’s Shockwave Javelin intravascular lithotripsy catheter treats people with peripheral artery disease. Elsewhere, Medtronic ...
On September 15, 2025, Johnson & Johnson (NYSE:JNJ) announced the European launch of its Shockwave Javelin Peripheral IVL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback